Evidence has also supported the notion that aberrant expression of TYRO3 contributed to tumorigenesis and metastasis in colon cancer, suggesting TYRO3 as a drug target in cancer therapy [12]. The gene discussed is TYRO3; the disease is malignant colon neoplasm.